个性化治疗中的癌症干细胞:机制,微环境交叉声和治疗脆弱性
Ling Yin1,2,3,4,5, Shoubing Zhou6, Hongliang Zhang1
1Center of Disease Immunity and Intervention, College of Medicine, Lishui University, Lishui, China.
Frontiers in cell and developmental biology
|August 14, 2025
概括
癌症干细胞 (CSC) 通过独特的生物学驱动瘤的进展和抵抗. 用新型疗法针对CSC提供了改善患者治疗结果和预防复发的潜力.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 癌症干细胞 (CSCs) 是瘤进展,转移和治疗抵抗的关键驱动因素.
- CSCs具有独特的膜生物学,糖化模式和代谢适应,这有助于它们的弹性.
- 独特的葡萄糖形状,包括氨酸和化甘氨酸,有助于CSCs在免疫逃避和生存.
研究的目的:
- 审查癌症干细胞 (CSCs) 的独特生物特征.
- 探索关键的信号通路,调节CSC的干度和抵抗.
- 讨论新兴的生物标志物,向疗法和CSC特征和治疗的先进技术.
主要方法:
- 审查有关癌症干细胞生物学,信号通路,生物标志物和治疗策略的当前文献.
- 在CSC研究中分析单细胞体质学,CRISPR查和患者衍生器官 (PDO) 的进展.
- 讨论标准化有机体培养,复制瘤微环境和克服CSC可塑性的挑战.
主要成果:
- CSCs利用不同的膜生物学,糖化和代谢适应来促进瘤的进展和治疗耐药性.
- 关键的信号通路 (Wnt/β-catenin,刺,Notch,JAK/STAT,TGF/SMAD,PI3K/AKT/mTOR) 对于中枢细胞干和耐药性至关重要.
- 新兴的生物标志物 (CD44,CD133,ALDH1,EpCAM) 和疗法 (CAR-T细胞,miRNA调节,脂质代谢抑制剂) 是有前途的.
- 像单细胞奥米克和PDOs这样的先进技术改善了CSC的表征和精确医学.
结论:
- 将CSC向策略与传统疗法相结合,对于根除耐疗群体和预防复发至关重要.
- 需要创新的组合疗法来克服CSC性并改善临床结果.
- 解决生物标志物验证,治疗耐药性和翻译应用方面的挑战对于推进CSC向治疗至关重要.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K


